BridgeMD
New treatment option for Total Shoulder Arthroplasty
Official title Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
ClinicalTrials.gov ID: NCT06143306
What this study is testing
What is bupivacaine.?
bupivacaine. is an investigational medicine, being studied as a potential treatment for total shoulder arthroplasty.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The use of ISB in patients undergoing total shoulder arthroplasty (TSA) is the gold standard and results in significantly reduced pain scores and opioid use. However, patients still have pain and the majority require opioids postoperatively as the interscalene block (ISB) doesn't cover all of the dermatomes impacted during TSA.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty;
- Patients aged 18-85 years old.
You likely can't join if
- Patients who have an exclusion to regional anesthesia such as pre-existing nerve damage to their brachial plexus or infection at the site of...
- Patients who have exclusion to interscalene blockade such as severe lung disease.
- Non-English speakers will be excluded because pain scales are not validated in other languages and there is lack of standardization of pain reporting.
- Pregnant patients
- Patients who are currently using opioids and patients with a diagnosis of chronic pain will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.